Arvinas Inc share price logo

Arvinas Inc

NASDAQ: ARVN

Small Cap

$10.78

+0.27

(+2.57%)

as on

Arvinas Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.84
    $10.94
    downward going graph

    8.72%

    Downside

    1.48%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.90
    $14.51
    downward going graph

    45.27%

    Downside

    34.60%

    Upside

    downward going graph

Arvinas Inc share price movements today

Previous Close
$10.51
Open
$10.02
Volume
1.3M
Day's Low - High
$9.84 - $10.94
52 Week Low - High
$5.90 - $14.51

Arvinas Inc Historical Returns

1 Month Return
-3.13 %
3 Month Return
-18.9 %
1 Year Return
+ 37.75 %
3 Year Return
-58.46 %
5 Year Return
-84.35 %

Arvinas Inc Stock Fundamentals & Key Indicators

Check Arvinas Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$672.2M

EPS (TTM)

-3.4663

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-111.9M

Revenue (TTM)

262.6M

Profit Margin

-30.77%

Return On Equity TTM

-16.23%

Arvinas Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arvinas Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Arvinas Inc image
Arvinas Inc
BUY$672.2M-84.35%NA-30.77%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.5B123.19%74.5912.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$107.8B98.21%27.7132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA118.975.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B45.4%17.1229.65%

Stock Returns calculator for Arvinas Inc Stock including INR - Dollar returns

The Arvinas Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arvinas Inc investment value today

Current value as on today

₹1,59,340

Returns

₹59,340

(+59.34%)

Returns from Arvinas Inc Stock

₹41,284 (+41.28%)

Dollar Impact

₹18,056 (+18.06%)

Analyst Recommendation on Arvinas Inc Stock

Based on 26 analysts

BUY

88.46%

Buy

11.54%

Hold

0.00%

Sell

Based on 26 analysts, 88.46% of analysts recommend a 'BUY' rating for Arvinas Inc. Average target price of $14.88

Arvinas Inc Share Price Target

Get share price movements and forecasts by analysts on Arvinas Inc.

What analysts predicted

27.55%UPSIDE

Target Price

$14.88

Current Price

$10.78

Analyzed by

26 Analysts

Target

$14.88

Arvinas Inc target price $14.88, a slight upside of 27.55% compared to current price of $10.78. According to 26 analysts rating.

Arvinas Inc Stock’s Investor Sentiment and Interest

Search interest for Arvinas Inc Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Arvinas Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
34
-43
25
76
102
59
188
22
41
9
Gross Profit
32
-44
23
74
102
59
188
22
41
8
Operating Income
-73
-165
-83
-48
-60
-58
71
-71
-43
-71
EBITDA
-62
-163
-81
-46
-59
-56
72
-70
-34
-66
Interest Expense
-
7
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-64
-153
-69
-35
-48
-45
83
-61
-34
-67
Income Tax Expense
0
1
0
0
0
0
0
0
0
0
Net Income
-64
-154
-69
-35
-49
-45
82
-61
-35
-67
Net Profit Margin
-184.97%
359.16%
-274.31%
-46.01%
-48.05%
-76.18%
43.91%
-273.21%
-83.77%
-709.47%

Arvinas Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
7
14
42
21
46
131
78
263
262
Gross Profit
6
7
14
42
21
46
131
78
263
257
Operating Income
-16
-24
-43
-51
-124
-195
-263
-401
-250
-114
EBITDA
-13
-23
-43
-49
-120
-189
-255
-394
-243
-75
Interest Expense
0
0
0
0
0
0
12
-
-
-
Depreciation
-
0
0
2
4
6
8
7
6
5
Income Before Tax
-14
-24
-41
-70
-119
-191
-251
-366
-198
-80
Income Tax Expense
0
0
2
-8
-7
-7
20
0
0
0
Net Income
-14
-24
-41
-62
-111
-183
-271
-367
-198
-80
Net Profit Margin
-215.18%
-317.32%
-289.59%
-144.57%
-512.74%
-392.29%
-206.93%
-467.90%
-75.51%
-30.77%

Arvinas Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-154
-69
-35
-49
-45
82
-61
-35
-67
Operating Cash Flow
-83
-97
50
-128
-84
-88
-95
-59
-30
Investing Cash Flow
-53
-127
13
50
98
69
128
63
145
Financing Cash Flow
334
1
3
2
0
0
0
-17
-74
Change in Cash
198
-223
66
-75
15
-19
33
-13
41

Arvinas Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Operating Cash Flow
5
-16
-40
-89
559
-273
-347
-259
-273
Investing Cash Flow
20
-179
-93
164
-1,313
242
203
34
407
Financing Cash Flow
0
168
139
504
278
4
374
7
-91
Change in Cash
25
-27
6
579
-475
-26
230
-216
42

Global Institutional Holdings in Arvinas Inc

Funds
Holdings
Pfizer Inc
5.41%
Point72 Asset Management, L.P.
3.62%
State Street Corp
2.93%
Federated Hermes Inc
1.71%
Qube Research & Technologies
2.32%
See all

Arvinas Inc News & Key Events

  • img

    Today's Timeline - 17 September

    Thu, 02:00 AM

    -

    Arvinas and Pfizer to out-license vepdegestrant commercialization rights; $100 million stock repurchase program authorized.

Insights on Arvinas Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ARVN has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Arvinas Inc has experienced a drawdown of -58.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 50.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 41.9M → 9.5M (in $), with an average decrease of 77.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -35.1M → -67.4M (in $), with an average decrease of 92.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ARVN stock has moved down by -18.9%

About Arvinas Inc

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
OrganisationArvinas Inc
Headquarters5 Science Park, New Haven, CT, United States, 06511
IndustryBiotechnology
CEOMr. David K. Loomis M.B.A.
E-voting on sharesClick here to vote

Key Management of Arvinas Inc

Name

Title

Mr. Steve Weiss

Senior VP & Chief Human Resources Officer

Mr. Paul McInulty

Senior Vice President of Regulatory Affairs

Mr. Alexander A. Santini

Chief Commercial Officer

Ms. Kelly Page

Senior VP & Global Head of Oncology Strategy and Program Leadership

Mr. David K. Loomis M.B.A.

VP & Chief Accounting Officer

Mr. Jeff Boyle

Vice President of Investor Relations

Mr. Jared M. Freedberg J.D.

General Counsel & Corporate Secretary

FAQs

What is Arvinas Inc share price today?

Arvinas Inc share price today is $10.78 as on at the close of the market. Arvinas Inc share today touched a day high of $10.94 and a low of $9.84.

What is the 52 week high and 52 week low for Arvinas Inc share?

Arvinas Inc share touched a 52 week high of $14.51 on and a 52 week low of $5.9 on . Arvinas Inc stock price today i.e. is closed at $10.78,which is 25.71% down from its 52 week high and 82.71% up from its 52 week low.

What is Arvinas Inc's market capitalisation today?

Arvinas Inc market capitalisation is $0.00T as on .

How to invest in Arvinas Inc Stock (ARVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arvinas Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arvinas Inc Shares that will get you 0.1391 shares as per Arvinas Inc share price of $10.78 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Arvinas Inc Stock (ARVN) from India?

Indian investors can start investing in Arvinas Inc (ARVN) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Arvinas Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arvinas Inc share’s latest price of $10.78 as on May 5, 2026 at 1:29 am IST, you will get 0.9276 shares of Arvinas Inc. Learn more about fractional shares .

What are the returns that Arvinas Inc has given to Indian investors in the last 5 years?

Arvinas Inc stock has given -84.35% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?